NCT02406612View on ClinicalTrials.gov

X-Seal EU Post-Market Clinical Follow-Up Protocol

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

June 30, 2016

Conditions
Femoral Arteriotomy Closure
Interventions
DEVICE

X-Seal 6F Vascular Closure Device

Trial Locations (2)

Unknown

University of Lubeck Hospital, Lübeck

University of Rostock Hosptial, Rostock

Sponsors
All Listed Sponsors
lead

Essential Medical, Inc.

INDUSTRY

NCT02406612 - X-Seal EU Post-Market Clinical Follow-Up Protocol | Biotech Hunter | Biotech Hunter